Dr Reddy's Laboratories (DRREDDY) Stock Price, News & Analysis

Company Overview

Dr Reddy’s Laboratories is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984 by Dr. K. Anji Reddy, the company has grown into a leading provider of generic and specialty medicines. It operates a network of manufacturing facilities, research centers and commercial offices across Asia, Europe, North America and other emerging markets.

The company’s core business encompasses the development, manufacture and marketing of active pharmaceutical ingredients (APIs), finished dosage formulations and biosimilars. Its product portfolio spans therapeutic areas such as oncology, gastroenterology, cardiology, dermatology and pain management. In addition to generics, Dr Reddy’s maintains programs for novel drug discovery and contract research and manufacturing services (CRAMS) for global partners.

Dr Reddy’s serves patients in more than 25 countries, with a particularly strong presence in the United States, India, Russia and the Commonwealth of Independent States (CIS). Its global manufacturing network includes facilities approved by regulatory bodies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), ensuring adherence to stringent quality standards.

Leadership is anchored by Chief Executive Officer Erez Israeli, who joined the company in 2019 and assumed the CEO role in 2020. Under his guidance, Dr Reddy’s continues to expand its R&D capabilities and pursue strategic collaborations aimed at delivering affordable, high-quality medicines to patients worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DRREDDY Stock Analysis - Frequently Asked Questions

How do I buy shares of Dr Reddy's Laboratories?

Shares of DRREDDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DRREDDY
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A